News

Updates from NHS BSA, MHRA drug safety alerts, and other medical news.

Depemokimab added to NHS dm+d — what event medics need to know

Depemokimab: a new biologic for eosinophilic asthma The NHS BSA has added depemokimab to the dm+d dictionary (version 6.0.0). This is a monoclonal antibody that targets the interleukin-4 receptor, used to treat moderate-to-severe eosinophilic asthma in patients with elevated blood eosinophils (≥300 cells/μL). What is depemokimab used for? Depemokimab is a biologic immunosuppressant given by […]